Tag: CymaBay Therapeutics
November 4, 2019
CymaBay Therapeutics Reaches Target Enrollment in ENHANCE Phase 3 Study
The study is evaluating its seladelpar in patients with primary biliary cholangitis with enrollment to be completed by end of... June 18, 2019